These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 29439885)

  • 21. Risk for surgical complications after previous stereotactic body radiotherapy of the spine.
    Roesch J; Cho JBC; Fahim DK; Gerszten PC; Flickinger JC; Grills IS; Jawad M; Kersh R; Letourneau D; Mantel F; Sahgal A; Shin JH; Winey B; Guckenberger M
    Radiat Oncol; 2017 Sep; 12(1):153. PubMed ID: 28893299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early magnetic resonance imaging biomarkers to predict local control after high dose stereotactic body radiotherapy for patients with sarcoma spine metastases.
    Spratt DE; Arevalo-Perez J; Leeman JE; Gerber NK; Folkert M; Taunk NK; Alektiar KM; Karimi S; Lyo JK; Tap WD; Bilsky MH; Laufer I; Yamada Y; Osborne JR
    Spine J; 2016 Mar; 16(3):291-8. PubMed ID: 26325017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-Fraction Spine Stereotactic Body Radiation Therapy for the Treatment of Chordoma.
    Jung EW; Jung DL; Balagamwala EH; Angelov L; Suh JH; Djemil T; Magnelli A; Chao ST
    Technol Cancer Res Treat; 2017 Jun; 16(3):302-309. PubMed ID: 27260562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases.
    Wang CJ; Christie A; Lin MH; Jung M; Weix D; Huelsmann L; Kuhn K; Meyer J; Desai N; Kim DWN; Pedrosa I; Margulis V; Cadeddu J; Sagalowsky A; Gahan J; Laine A; Xie XJ; Choy H; Brugarolas J; Timmerman R; Hannan R
    Int J Radiat Oncol Biol Phys; 2017 May; 98(1):91-100. PubMed ID: 28587057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Marginal recurrence requiring salvage radiotherapy after stereotactic body radiotherapy for spinal metastases.
    Koyfman SA; Djemil T; Burdick MJ; Woody N; Balagamwala EH; Reddy CA; Angelov L; Suh JH; Chao ST
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):297-302. PubMed ID: 21985940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consensus guidelines for postoperative stereotactic body radiation therapy for spinal metastases: results of an international survey.
    Redmond KJ; Lo SS; Soltys SG; Yamada Y; Barani IJ; Brown PD; Chang EL; Gerszten PC; Chao ST; Amdur RJ; De Salles AA; Guckenberger M; Teh BS; Sheehan J; Kersh CR; Fehlings MG; Sohn MJ; Chang UK; Ryu S; Gibbs IC; Sahgal A
    J Neurosurg Spine; 2017 Mar; 26(3):299-306. PubMed ID: 27834628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salvage Stereotactic Body Radiotherapy (SBRT) Following In-Field Failure of Initial SBRT for Spinal Metastases.
    Thibault I; Campbell M; Tseng CL; Atenafu EG; Letourneau D; Yu E; Cho BC; Lee YK; Fehlings MG; Sahgal A
    Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):353-60. PubMed ID: 26383680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-fraction versus multifraction spinal stereotactic radiosurgery for spinal metastases from renal cell carcinoma: secondary analysis of Phase I/II trials.
    Ghia AJ; Chang EL; Bishop AJ; Pan HY; Boehling NS; Amini B; Allen PK; Li J; Rhines LD; Tannir NM; Tatsui CE; Brown PD; Yang JN
    J Neurosurg Spine; 2016 May; 24(5):829-36. PubMed ID: 26799117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vertebral compression fracture (VCF) after spine stereotactic body radiation therapy (SBRT): analysis of predictive factors.
    Cunha MV; Al-Omair A; Atenafu EG; Masucci GL; Letourneau D; Korol R; Yu E; Howard P; Lochray F; da Costa LB; Fehlings MG; Sahgal A
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e343-9. PubMed ID: 22658511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereotactic Body Radiation Therapy for Spinal Malignancies.
    Osborn VW; Lee A; Yamada Y
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818802304. PubMed ID: 30343661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereotactic radiosurgery for spinal metastases with or without separation surgery.
    Bate BG; Khan NR; Kimball BY; Gabrick K; Weaver J
    J Neurosurg Spine; 2015 Apr; 22(4):409-15. PubMed ID: 25635638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for vertebral compression fracture after spine stereotactic body radiation therapy: Long-term results of a prospective phase 2 study.
    Mantel F; Sweeney RA; Klement RJ; Hawkins MA; Belderbos J; Ahmed M; Toussaint A; Polat B; Flentje M; Guckenberger M
    Radiother Oncol; 2019 Dec; 141():62-66. PubMed ID: 31526672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stereotactic body radiotherapy for de novo spinal metastases: systematic review.
    Husain ZA; Sahgal A; De Salles A; Funaro M; Glover J; Hayashi M; Hiraoka M; Levivier M; Ma L; Martínez-Alvarez R; Paddick JI; Régis J; Slotman BJ; Ryu S
    J Neurosurg Spine; 2017 Sep; 27(3):295-302. PubMed ID: 28598293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroimaging and Stereotactic Body Radiation Therapy (SBRT) for Spine Metastasis.
    Khan M; Garg R; Gui C; Lee Y; Sahgal A; Mossa-Basha M; Mayr N; Lo S; Redmond K
    Top Magn Reson Imaging; 2019 Apr; 28(2):85-96. PubMed ID: 31022051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control.
    Stinauer MA; Kavanagh BD; Schefter TE; Gonzalez R; Flaig T; Lewis K; Robinson W; Chidel M; Glode M; Raben D
    Radiat Oncol; 2011 Apr; 6():34. PubMed ID: 21477295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereotactic radiosurgery for spinal metastases from renal cell carcinoma.
    Gerszten PC; Burton SA; Ozhasoglu C; Vogel WJ; Welch WC; Baar J; Friedland DM
    J Neurosurg Spine; 2005 Oct; 3(4):288-95. PubMed ID: 16266070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of epidural progression following postoperative spine stereotactic body radiotherapy: implications for clinical target volume delineation.
    Chan MW; Thibault I; Atenafu EG; Yu E; John Cho BC; Letourneau D; Lee Y; Yee A; Fehlings MG; Sahgal A
    J Neurosurg Spine; 2016 Apr; 24(4):652-9. PubMed ID: 26682603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spine stereotactic radiosurgery with concurrent tyrosine kinase inhibitors for metastatic renal cell carcinoma.
    Miller JA; Balagamwala EH; Angelov L; Suh JH; Rini B; Garcia JA; Ahluwalia M; Chao ST
    J Neurosurg Spine; 2016 Dec; 25(6):766-774. PubMed ID: 27391397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantifying the changes in the tumour vascular micro-environment in spinal metastases treated with stereotactic body radiotherapy - a single arm prospective study.
    Vellayappan B; Cheong D; Singbal S; Tey J; Yang Soon Y; Nang Leong C; Wong A; Lwin S; Hung Lee C; Periasamy P; Lo S; Kumar N
    Radiol Oncol; 2022 Dec; 56(4):525-534. PubMed ID: 36503714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oligometastatic Disease State Is Associated with Improved Local Control in Patients Undergoing Three or Five Fraction Spine Stereotactic Body Radiotherapy.
    Silva SR; Gliniewicz A; Martin B; Prabhu VC; Germanwala AV; Melian E; Jones GA; Solanki AA
    World Neurosurg; 2019 Feb; 122():e342-e348. PubMed ID: 30326310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.